Early-onset pancreatic cancer patients benefit more from neoadjuvant chemotherapy and surgery Post author:admin Post published:August 7, 2025 Post category:uncategorized The incidence of early-onset pancreatic cancer (EOPC) is rising, yet optimal treatment strategies remain unclear. You Might Also Like Community voices redefine well-being: Ontario study highlights residents’ priorities November 26, 2023 Review reveals high rates of opioid dependence among chronic pain patients August 8, 2024 New blood atlas reveals how diseases leave unique protein signatures October 9, 2025
Community voices redefine well-being: Ontario study highlights residents’ priorities November 26, 2023